• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Predicting work status in patients with schizophrenia

Bioengineer by Bioengineer
August 21, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Sumiyoshi, C., et al., Schizophr. Res. (2018), DOI: 10.1016/j.schres.2018.05.042

Schizophrenia is a mental disorder that occurs in one out of every 100 people. Its symptoms include positive symptoms, such as hallucinations and delusions, and negative symptoms, such as social withdrawal, apathy, and cognitive impairments. In many cases, these symptoms become chronic and relapse. In addition, many patients with schizophrenia show deterioration of intelligence, which prevents them from independent living in their community, and joining the work force, in particular.

A research team led by Ryota Hashimoto at Osaka University clarified that IQ decline, defined as a difference between current full scale IQ (FIQ) and estimated premorbid IQ, was related to work status in patients with schizophrenia. The researchers also proposed a method for estimating probabilities of work outcome in those patients based on related factors, such as IQ decline, social function, and psychiatric symptoms. Their research results were published in Schizophrenia Research.

First, various variables were compared between the preserved group (patients with preserved IQ), the deteriorated group (patients whose current intelligence was lower than their estimated premorbid intelligence), and the healthy controls (the group of healthy volunteers).

Next, they performed logistic regression analyses to predict work status in patients with schizophrenia using the significant variables found in the group comparisons. The work status was dichotomized by a criterion of 1, 10, 20, or 30 hours per week. At each criterion, patients were classified into either the above or the below criterion according to their actual work hours.

The analyses demonstrated that IQ decline was effective for predicting work status. Based on the equations obtained from the logistic regression models, they also presented a method for predicting probabilities for working longer than each criterion.

The first author Chika Sumiyoshi at Fukushima University says, "The amount of work performed by patients with schizophrenia was predicted by doctors only based on their experience and intuition. Our research results will help them to explain how many hours patients can work to them and their families based on objective data and promote consensus-building between the patient and physician. This will help motivate patients to receive treatment and promote their reintegration into society.

###

The article, "Predicting work outcome in patients with schizophrenia: Influence of IQ decline" was published in Schizophrenia Research, https://doi.org/10.1016/j.schres.2018.05.042.

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: http://resou.osaka-u.ac.jp/en/top

Media Contact

Saori Obayashi
[email protected]
81-661-055-886
@osaka_univ_e

http://www.osaka-u.ac.jp/en

Original Source

http://resou.osaka-u.ac.jp/en/research/2018/20180629_2 http://dx.doi.org/10.1016/j.schres.2018.05.042

Share14Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.